|
2010 |
Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. |
Roberta Diaz Brinton, Ph.D |
|
2021 |
Methionine restriction alleviates age-associated cognitive decline via fibroblast growth factor 21. |
Fei Yin, Ph.D. |
|
2022 |
Microencapsulation and incubation methodology for the cultivation of marine bacteria. |
Christopher Cartmell |
|
2022 |
Microencapsulation and in situ incubation methodology for the cultivation of marine bacteria |
|
|
2019 |
Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2012 |
Minireview: translational animal models of human menopause: challenges and emerging opportunities. |
Roberta Diaz Brinton, Ph.D |
|
2021 |
Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2009 |
Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. |
Frank Porreca, PhD |
|
2020 |
Multifaceted roles of TAK1 signaling in cancer. |
Nam Lee, Ph.D. |
|
2003 |
Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. |
|
|
2015 |
My Obstetrician Got Me Fired: How Work Notes Can Harm Pregnant Patients and What to Do About It. |
Sigrid Gardner Williams |
|
2019 |
Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation. |
Fei Yin, Ph.D. |
|
2016 |
Neuroendocrinology: Oestrogen therapy affects brain structure but not function. |
Roberta Diaz Brinton, Ph.D |
|
2014 |
Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. |
Frank Porreca, PhD |
|
2011 |
Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2013 |
Neurosteroids as regenerative agents in the brain: therapeutic implications. |
Roberta Diaz Brinton, Ph.D |
|
2009 |
Novel bifunctional peptides as opioid agonists and NK-1 antagonists. |
Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2008 |
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2013 |
Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. |
Victor Hruby, Ph.D., Todd Vanderah, PhD |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2011 |
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD, FAAPS |
|
2009 |
Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. |
Roberta Diaz Brinton, Ph.D |
